Assessment of paired tumor biopsy samples from three patients by immunohistochemistry showed that treatment with mivavotinib resulted in changes in population numbers of CD8, CD4, Treg, NK, and B cells in the tumor. The gene discussed is CD8A; the disease is neoplasm.